These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32674668)

  • 21. Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.
    Stebelska K
    Ther Drug Monit; 2013 Aug; 35(4):420-42. PubMed ID: 23851905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.
    Balon R
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):515-516. PubMed ID: 36251379
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry.
    Goff R; Smith M; Islam S; Sisley S; Ferguson J; Kuzdzal S; Badal S; Kumar AB; Sreenivasan U; Schug KA
    Anal Chim Acta; 2024 Feb; 1288():342161. PubMed ID: 38220293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.
    Cavanna F; Muller S; de la Fuente LA; Zamberlan F; Palmucci M; Janeckova L; Kuchar M; Pallavicini C; Tagliazucchi E
    Transl Psychiatry; 2022 Aug; 12(1):307. PubMed ID: 35918311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.
    Bienemann B; Barbosa AR; Cruz LVMD; Multedo M; Mograbi D
    J Psychoactive Drugs; 2024; 56(3):324-332. PubMed ID: 37348116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Suicide under the influence of "magic mushrooms"].
    Müller K; Püschel K; Iwersen-Bergmann S
    Arch Kriminol; 2013; 231(5-6):193-8. PubMed ID: 23878898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME; Portier CB; Franssen EJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Between prohibitions: patterns and meanings of magic mushroom use in the UK.
    Riley SC; Blackman G
    Subst Use Misuse; 2008; 43(1):55-71. PubMed ID: 18189205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.
    Pepe M; Hesami M; de la Cerda KA; Perreault ML; Hsiang T; Jones AMP
    Biotechnol Adv; 2023 Dec; 69():108247. PubMed ID: 37659744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.
    Bienemann B; Ruschel NS; Campos ML; Negreiros MA; Mograbi DC
    PLoS One; 2020; 15(2):e0229067. PubMed ID: 32084160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magic truffles or Philosopher's stones: a legal way to sell psilocybin?
    Pellegrini M; Rotolo MC; Marchei E; Pacifici R; Saggio F; Pichini S
    Drug Test Anal; 2013 Mar; 5(3):182-5. PubMed ID: 22887928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.
    Borowiak KS; Ciechanowski K; Waloszczyk P
    J Toxicol Clin Toxicol; 1998; 36(1-2):47-9. PubMed ID: 9541042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peak experiences of psilocybin users and non-users.
    Cummins C; Lyke J
    J Psychoactive Drugs; 2013; 45(2):189-94. PubMed ID: 23909006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.